Real-World Clinical Outcomes and Replacement Factor VIII Consumption in Patients with Haemophilia A in Italy: A Comparison between Prophylaxis Pre and Post Octocog Alfa (BAY 81-8973)

(1) Background: new generations of rFVIII products offered the possibility to improve personalized therapeutic approaches, reducing the number of infusions or increasing the protection against bleeding risk. The aim of this study was to assess the effectiveness of prophylaxis with BAY 81-8973 (octoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Cortesi, Paolo Angelo, Di Minno, Giovanni, Zanon, Ezio, Giuffrida, Gaetano, Santoro, Rita Carlotta, Marino, Renato, D’Angiolella, Lucia Sara, Antonazzo, Ippazio Cosimo, Squassabia, Ginevra, Clemente, Francesco, Di Laura, Danilo, Cimino, Ernesto, Pasca, Samantha, Nicolosi, Daniela, Mantovani, Lorenzo Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224869/
https://www.ncbi.nlm.nih.gov/pubmed/35743504
http://dx.doi.org/10.3390/jcm11123434

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224869/
https://www.ncbi.nlm.nih.gov/pubmed/35743504
http://dx.doi.org/10.3390/jcm11123434

Ejemplares similares